世界のウェアラブルインジェクター市場2021-2028:種類別(オンボディ、オフボディ)、技術別(ばね式、モーター式)、用途別(腫瘍、自己免疫疾患)、最終用途別

◆英語タイトル:Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By Application (Oncology, Autoimmune Diseases), By End Use, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC070
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界のウェアラブルインジェクター市場規模が2028年までに183憶ドルに達すると予測しています。2021年から2028年までに年平均17.2%成長する見通しです。本調査レポートでは、ウェアラブルインジェクターの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、種類別(オンボディ、オフボディ)分析、技術別(ばね式、モーター式、ロータリーポンプ式、拡張電池式、その他)分析、用途別(腫瘍、感染症、心血管疾患、自己免疫疾患、その他)分析、最終用途別(病院、診療所、在宅医療、その他)分析、地域別分析、競争状況などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・ウェアラブルインジェクターの世界市場規模:種類別(オンボディ、オフボディ)
・ウェアラブルインジェクターの世界市場規模:技術別(ばね式、モーター式、ロータリーポンプ式、拡張電池式、その他)
・ウェアラブルインジェクターの世界市場規模:用途別(腫瘍、感染症、心血管疾患、自己免疫疾患、その他)
・ウェアラブルインジェクターの世界市場規模:最終用途別(病院、診療所、在宅医療、その他)
・ウェアラブルインジェクターの世界市場規模:地域別
・競争状況
【レポートの概要】

Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

Wearable Injectors Market Report Highlights

• By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin

• The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes

• The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic

• North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Technology
1.1.3. Application
1.1.4. End Use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
1.9.3. Objective 3:
1.9.4. Objective 4:
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Wearable Injectors Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Wearable Injectors Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Wearable Injectors Market Share, 2020 & 2028
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.4.1. On-body
4.4.2. Off-body
Chapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Definitions and Scope
5.3. Wearable Injectors Market Share, 2020 & 2028
5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.4.1. Spring-based
5.4.2. Motor-driven
5.4.3. Rotary Pump
5.4.4. Expanding Battery
5.4.5. Others
Chapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Definitions and Scope
6.3. Wearable Injectors Market Share, 2020 & 2028
6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.4.1. Oncology
6.4.2. Infectious Diseases
6.4.3. Cardiovascular Diseases
6.4.4. Autoimmune Diseases
6.4.5. Others
Chapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Definitions and Scope
7.3. Wearable Injectors Market Share, 2020 & 2028
7.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Home Care
7.4.4. Others
Chapter 8. Wearable Injectors: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2020 & 2028
8.3. Regional Market Share, 2020
8.4. North America
8.4.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.4.2. U.S.
8.4.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.4.3. Canada
8.4.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.5. Europe
8.5.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.5.2. U.K.
8.5.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.5.3. Germany
8.5.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.5.4. France
8.5.4.1. France estimates and forecast, 2016 – 2028 (USD Million)
8.6. Asia Pacific
8.6.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.6.2. Japan
8.6.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.6.3. China
8.6.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.7. Latin America
8.7.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.7.2. Brazil
8.7.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.7.3. Mexico
8.7.3.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.8. MEA
8.8.1. Market estimates and forecast, 2016 – 2028 (USD Million)
8.8.2. South Africa
8.8.2.1. Market estimates and forecast, 2016 – 2028 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.1.1. Becton, Dickinson and Company
9.1.1.1. Company overview
9.1.1.2. Financial performance
9.1.1.3. Product benchmarking
9.1.1.4. Strategic initiatives
9.1.2. Johnson & Johnson Services, Inc.
9.1.2.1. Company overview
9.1.2.2. Financial performance
9.1.2.3. Product benchmarking
9.1.2.4. Strategic initiatives
9.1.3. F. Hoffmann-La Roche Ltd.
9.1.3.1. Company overview
9.1.3.2. Financial performance
9.1.3.3. Product benchmarking
9.1.3.4. Strategic initiatives
9.1.4. Unilife Corporation
9.1.4.1. Company overview
9.1.4.2. Financial performance
9.1.4.3. Product benchmarking
9.1.4.4. Strategic initiatives
9.1.5. SteadyMed Therapeutics, Inc.
9.1.5.1. Company overview
9.1.5.2. Financial performance
9.1.5.3. Product benchmarking
9.1.5.4. Strategic initiatives
9.1.6. Amgen Inc.
9.1.6.1. Company overview
9.1.6.2. Financial performance
9.1.6.3. Product benchmarking
9.1.6.4. Strategic initiatives
9.1.7. Insulet Corporation
9.1.7.1. Company overview
9.1.7.2. Financial performance
9.1.7.3. Product benchmarking
9.1.7.4. Strategic initiatives
9.1.8. Enable Injections
9.1.8.1. Company overview
9.1.8.2. Financial performance
9.1.8.3. Product benchmarking
9.1.8.4. Strategic initiatives
9.1.9. West Pharmaceutical Services, Inc.
9.1.9.1. Company overview
9.1.9.2. Financial performance
9.1.9.3. Product benchmarking
9.1.9.4. Strategic initiatives
9.1.10. CeQur SA
9.1.10.1. Company overview
9.1.10.2. Financial performance
9.1.10.3. Product benchmarking
9.1.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global Wearable Injectors Market, by Region 2016 - 2028 (USD Million)
Table 4 Global Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 5 Global Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 6 Global Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 7 Global Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 8 North America Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
Table 9 North America Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 10 North America Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 11 North America Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 12 North America Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 13 U.S. Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 14 U.S. Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 15 U.S. Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 16 U.S. Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 17 Canada Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 18 Canada Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 19 Canada Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 20 Canada Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 21 Europe Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
Table 22 Europe Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 23 Europe Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 24 Europe Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 25 Europe Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 26 U.K. Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 27 U.K. Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 28 U.K. Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 29 U.K. Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 30 Germany Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 31 Germany Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 32 Germany Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 33 Germany Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 34 France Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 35 France Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 36 France Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 37 France Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 38 Asia Pacific Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
Table 39 Asia Pacific Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 40 Asia Pacific Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 41 Asia Pacific Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 42 Asia Pacific Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 43 Japan Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 44 Japan Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 45 Japan Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 46 Japan Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 47 China Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 48 China Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 49 China Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 50 China Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 51 Latin America Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
Table 52 Latin America Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 53 Latin America Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 54 Latin America Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 55 Latin America Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 56 Brazil Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 57 Brazil Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 58 Brazil Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 59 Brazil Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 60 Mexico Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 61 Mexico Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 62 Mexico Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 63 Mexico Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 64 MEA Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
Table 65 MEA Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 66 MEA Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 67 MEA Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 68 MEA Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
Table 69 South Africa Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
Table 70 South Africa Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
Table 71 South Africa Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
Table 72 South Africa Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Wearable Injectors market: Market snapshot
Fig. 9 Wearable Injectors market: Market segmentation
Fig. 10 Wearable Injectors market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Wearable Injectors market driver impact
Fig. 14 Wearable Injectors market restraint impact
Fig. 15 Wearable Injectors market porter’s five forces analysis
Fig. 16 Wearable Injectors market PESTEL analysis
Fig. 17 Wearable Injectors market segment dashboard
Fig. 18 Wearable Injectors market: Type movement Analysis
Fig. 19 On-body market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 20 Off-body market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 21 Wearable Injectors market segment dashboard
Fig. 22 Wearable Injectors market: Technology movement Analysis
Fig. 23 Spring-based market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 24 Motor-driven market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Rotary Pump market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 26 Expanding Battery market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 27 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 28 Wearable Injectors market segment dashboard
Fig. 29 Wearable Injectors market: Application movement Analysis
Fig. 30 Oncology market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 Infectious diseases market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Cardiovascular diseases market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 Autoimmune diseases market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 Wearable Injectors market segment dashboard
Fig. 36 Wearable Injectors market: End-use movement Analysis
Fig. 37 Hospitals market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Clinics market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Home care market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 Global Wearable Injectors market: Regional movement analysis
Fig. 42 Global market share, by region
Fig. 43 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 50 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 53 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 54 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 55 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 56 Middle East and Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 57 South Africa market estimates and forecast, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のウェアラブルインジェクター市場2021-2028:種類別(オンボディ、オフボディ)、技術別(ばね式、モーター式)、用途別(腫瘍、自己免疫疾患)、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆